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Abstract
Background: Frailty has been deﬁned as a clinical syndrome of multicausal origin characterized by a reduction of physiologic
reserves that increase the vulnerability of an individual to adverse outcomes such as the development of functional dependence and
death. Considered one of themost important geriatric syndromes, frailty’s prevention andmanagement represent important goals for
gerontology and geriatrics. Although nutrition plays an important role within the multifactorial susceptibility for this syndrome, up to
the present no systematic review speciﬁcally addressed the effectiveness of nutritional interventions for the treatment of frailty.
Therefore, we propose the present systematic review with the aim to assess the effectiveness of nutritional interventions for the
treatment of frailty in older adults living in the community or in long-term care facilities.
Methods:Wewill searchMedline (via Pubmed), Embase, Cinahl, Central, Lilacs, Web of Science, and sources of gray literature. We
will accept trials whereby the unit of randomization consisted of individuals or clusters of individuals. Our primary outcome is all-cause
mortality. Secondary outcomes are quality of life, functional status, cognitive function, frailty status, body composition, and physical
activity. Risk of bias will be assessed using the Cochrane Collaboration tool. We will analyze the overall strength of the evidence for
each outcome using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool. Two independent
researchers will conduct all evaluations and any disagreements will be resolved through the participation of a 3rd author. If possible,
we will perform random-effects meta-analyses and subgroup analyses concerning speciﬁc details of nutritional interventions (e.g.,
components and duration), research scenario, risk of bias, and criteria used to diagnose frailty.
Conclusion: In this systematic review protocol we outline the details of the aims and methods of a systematic review on the
effectiveness of nutritional interventions for the management of frailty in older adults living in the community or in long-term care
facilities”. We believe this wording to be more objective and balanced than the previous one. We understand that it is not ideal to
propose changes to the text after manuscripts have been accepted. However, we feel that the newwording of the conclusion section
of the abstract is more consistent with the overall content of the main text of the review than its previous version. Hence, we hope you
may accept our request.
Abbreviations: GRADE = Grading of Recommendations Assessment, Development, and Evaluation, GRADEPRO = Grading of
Recommendations Assessment, Development, and Evaluation Proﬁler Software, ICTRP = World Health International Clinical Trials
Registry Platform, OPEN GRAY = Gray Literature in Europe, PROSPERO = International Prospective Register of Systematic
Reviews.
Keywords: aged, diet, dietary supplements, feeding, frailty, nutrition, systematic review
1. Introduction
Frailty has been deﬁned as a clinical syndrome of multicausal
origin characterized by a reduction of physiologic reserves that
increase the vulnerability of an individual to adverse outcomes
such as the development of functional dependence and death.[1]
Considered one of the most important geriatric syndromes,
frailty’s prevention and management represent important goals
for gerontology and geriatrics.[2] The concept of frailty has
greatly contributed to the development of this ﬁeld by
highlighting a multiplicity of subclinical factors (i.e., going
beyond the presence of functional dependence and comorbidities)
and contributing to the reduction of the capacity of older adults
to maintain their homeostasis when exposed to stressor events.[3]
In fact, studies using different operational deﬁnitions of frailty
have shown that it represents an important risk factor for a
variety of negative outcomes. For example, frail older adults were
found to be at an increased risk of falling by 84%, when
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compared to those who are nonfrail.[4] The frailty syndrome has
also been associated with 70% greater chance of fractures,[5]
30% increase in the risk of developing dementia,[6] and 90%
increase in the risk of hospitalization.[7] An inverse association
between frailty and quality of life of older adults living in the
community has also been observed.[8]
These data are especially relevantwhen one considers the results
of studies reporting the prevalence of this syndrome among older
adults and the perspectives of population aging worldwide.[9] A
systematic review on the prevalence of frailty among community-
dwelling elderly identiﬁed that prevalence ranged from 4% to
59%,with a weighted average of 11%.[10] A signiﬁcant increase in
the prevalence of this syndrome is also noted among individuals of
a more advanced age, reaching an average of about 27% among
adults older than 85 years of age.[11] Amid institutionalized older
adults, the prevalence of frailty ranged from 19% to 76%, with a
weighted average of 52%.[11]
An important meeting of experts, leading to the 1st successful
international consensus on the deﬁnition of frailty, considered
that there was some evidence suggesting possible beneﬁts of 4
types of interventions for managing this condition: physical
exercise, caloric and protein support, vitamin D supplementa-
tion, and reduction of polypharmacy.[1]
Loss of muscle mass is one of the consequences of weight loss in
older adults, along with reduction of strength, mobility, and
immune dysfunction, which represent typical characteristics of
frailty. In addition, malnutrition in older adults increases the risk
of hospitalization, functional dependence, and death in this
population.[12] The association between nutritional factors and
the occurrence of frailty was also observed in the systematic
review of Lorenzo-López et al that analyzed data from 19
observational studies.[13] The nutritional factors examined by
this review were micronutrients, macronutrients, diet quality,
antioxidants, and score in the Mini Nutritional Assessment.[13]
Due to the global phenomenon of population ageing,[2] the
increased prevalence of frailty at more advanced ages and the
negative consequences of this syndrome, studies about efﬁcacy
and effectiveness of interventions to manage this syndrome have
great importance, particularly aiming at the prevention of such
adverse events. In view of the relevance of the topic and the
arguments presented above, we propose the present systematic
review with the aim to assess the effectiveness of nutritional
interventions for the treatment of frailty in older adults living in
the community or in long-term care facilities.
2. Methods
2.1. Study registration
This systematic review protocol has been registered on
PROSPERO under the number of CRD42018111510, and
was performed in accordance with the Preferred Reporting Items
for Systematic Reviews and Meta-analysis Protocol.[14] This is a
literature-based study, so ethical approval is unnecessary.
2.2. Selection criteria
2.2.1. Types of studies. We will include only parallel-group
randomized clinical trials published since 2001 in English,
Portuguese, or Spanish. We will accept trials whereby the unit of
randomization consisted of individuals or clusters of individuals.
2.2.2. Types of participants. We will include studies that
recruited older adults (aged 60 years or older) with a diagnosis of
frailty or prefrailty and living in the community or in long-term
care facilities. We will accept any criteria used by original studies
to diagnose that syndrome. Studies that have been performed
during hospitalization episodes will not be included.
2.2.3. Types of interventions.We will include studies that have
implemented at least one of the following nutritional inter-
ventions: nutritional education/dietary prescription, the use of
hypercaloric or hyperproteic dietary oral supplements and the
delivery of speciﬁc diets. Additionally, we will also include studies
that adopted any of the above interventions concomitantly with
another single or multifactorial intervention provided that the
comparator was the same set of interventions without the
nutritional intervention component. We will accept as compa-
rators standard treatment, placebo, other nutritional interven-
tions, and multifactorial interventions without a nutritional
component.
2.2.4. Types of outcomes.Wewill include studies if they report
at least one of the following outcome measures.
2.2.4.1. Primary outcomes.
1. Mortality.
2.2.4.2. Secondary outcomes.
1. Quality of life, measured by any instrument
2. Functional capacity, measured by any instrument.
3. Cognitive function, measured by any instrument.
4. State of frailty, measured by any instrument.
5. Body composition, measured by any instrument.
6. Physical activity, measured by any instrument.
2.3. Search methods for study identiﬁcation
Two independent researchers will examine the lists of references
identiﬁed through electronic search. We will also hand-search
reference lists of relevant publications including review articles on
frailty and of original studies considered eligible for the review.
Additionally, we will contact experts in the ﬁeld of nutrition and
frailty to ask for references to published and unpublished data.
We also intend to contact researchers to request relevant
unpublished data whenever possible.
2.3.1. Electronic searches. We will search the following
databases for relevant studies, using the search terms detailed
in Appendix 1: http://links.lww.com/MD/C725 Medline (via
Pubmed), Embase, Cinahl, Central, Lilacs e Web of Science.
2.3.2. Other resources.We will search the following databases
for gray literature: System for information on Gray Literature in
Europe (Open Gray), Virginia Henderson Global Nursing e-
Repository, National Library of Medicine Bookshelf, Clinical-
Trials.gov, and World Health International Clinical Trials
Registry Platform (ICTRP).
2.4. Data collection and analysis
2.4.1. Selection of studies. For all studies identiﬁed, 2 authors
will independently screen and review the titles and abstracts. Full
versions of potentially relevant studies will be obtained. Where
applicable, we will contact the authors of selected studies to ask
for additional data. Disputes regarding the inclusion of a study
will be resolved through discussion with a 3rd reviewer.
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2.5. Data extraction and management
Two reviewers will extract data independently using a standard-
ized prepiloted form including the following data: complete
reference; time period when the study was conducted; geograph-
ical location; presence of divergences between the study protocol
and published results; study design; types of interventions and
comparators; duration of the intervention and of follow-up;
inclusion/exclusion criteria; sample size; characteristics of the
population; balance between groups at the baseline; funding
source; method of randomization; presence of simultaneous
interventions; diagnostic criteria of frailty; nutritional interven-
tions; details of the intervention, including type, dose, frequency,
and duration; control treatment; outcome measures; blinding
(patients, ﬁeld professionals and outcome assessors); duration of
follow-up; loss of follow-up; results; intention-to-treat analysis;
conclusions reported by the study authors; and research
limitations. In addition, there will be a ﬁeld for the registration
of other information deemed relevant by the reviewers.
Disagreements about extracted data will be resolved by
consensus, and an independent reviewer will be consulted if
disagreement persists.
2.5.1. Assessment of bias risk. To assess the risk of bias in the
included studies, 2 review authors will independently use The
Cochrane Collaboration’s Risk of Bias tool for randomized
clinical trials.[15] Accordingly, the following domains will be
assessed: random sequence generation, allocation concealment,
blinding, incomplete outcome data, selective reporting, and other
bias. Each of these criteria will be assigned one of the following
categories: low risk of bias; high risk of bias; or unclear risk of
bias, where unclear relates to the lack of precise information or
uncertainty over the potential for bias.
Where applicable, the investigators of selected trials will be
contacted to provide additional relevant information. Disagree-
ments between the authors regarding the assessment of risk of
bias will be resolved by consensus, and a 3rd reviewer will be
consulted when needed.
2.5.2. Rating quality of evidence.We will analyze the overall
strength of the evidence for each outcome using the Grading
of Recommendations Assessment, Development and Evalua-
tion (GRADE) tool. This system represents a method that
evaluates the quality of evidence in systematic reviews
explicitly, comprehensively, transparently, and pragmatical-
ly.[16] The GRADE system evaluates the following dimensions
regarding the quality of evidence: study limitations/risk of
bias, inconsistency, indirect effects, inaccuracy, publication
bias, and factors that may increase the quality of evidence.
According to GRADE, the quality of the evidence regarding
each outcome analyzed is classiﬁed into 1/4 levels: high,
moderate, low, and very low.[16]
We will use the GRADE proﬁler software (GRADEPRO) to
create “summary of ﬁndings” tables with outcome speciﬁc
information concerning the overall quality of evidence and the
magnitude of effect of the interventions examined by the
examined body of evidence.
2.5.3. Measures of treatment effects. Dichotomous data: the
results will be presented as the risk ratios with 95% conﬁdence
intervals. Continuous data: the results will be presented as the
mean difference, if outcomes are measured using similar scales
between trials. We will use the standardized mean difference to
combine trials that measure the same outcome using different
scales or instruments.
2.5.4. Unit of analysis issues. The appropriate unit of analysis
will be the individual patient, rather than hospitals or health
centers. In studies with multiple intervention groups, we will
include only the comparisons between groups that meet our
eligibility criteria. If more than 1 pair of intervention comparisons
are eligible for a given meta-analysis and those pairs of
comparisons have at least 1 intervention group in common,
we will proceed using one of the methods recommended by the
Cochrane Collaboration in the following order of preference
according to the feasibility of each approach: we will attempt to
merge the intervention groups to yield a single pairwise
comparison; we will attempt to account for the correlation
between correlated comparisons by calculating a weighted
average of the different pairwise comparisons; and we will
perform a network meta-analysis.
2.5.5. Missing data.Where applicable, we will contact the chief
investigators of clinical trials with missing data or unclear
information (e.g., unclear risk of bias). Whenever possible we will
include in meta-analyses data from intention-to-treat analyses.
We will not perform imputation procedures for missing data.
2.5.6. Assessment of reporting biases. If there are sufﬁcient
numbers of trials (at least 10), we will construct a funnel plot and
we will apply the Egger tests and the Trim and Fill method in the
evaluation of publication bias.
2.5.7. Data synthesis. We will organize the synthesis of data
according to the types of nutritional interventions studied, the
types of comparators, and populations studied (i.e., older adults
living in the community or in long-term care facilities).
If the included studies are sufﬁciently similar in terms of
population, inclusion criteria, interventions, and results, we will
perform quantitative synthesis using the random effects models.
2.5.8. Assessment of heterogeneity. If the available data
allow the performance of meta-analyses, we will assess
statistical heterogeneity by means of I2 statistics, which will
be interpreted according to the current Cochrane Collaboration
guidance as follows: 0% to 40% might not be important; 30%
to 60% may represent moderate heterogeneity; 50% to 90%
may represent substantial heterogeneity; 75% to 100%
considerable heterogeneity.[15] If we ﬁnd substantial heteroge-
neity, we will attempt to perform subgroup analyses as
described in the following sections.
2.5.9. Subgroup analyses. If sufﬁcient data are available, we
will perform the following subgroup analyses: concerning speciﬁc
details of nutritional interventions (e.g., components and
duration), research scenario (i.e., community or long-term care
facilities), risk of bias, and criteria used to diagnose frailty.
2.5.10. Sensitivity analysis.We have not planned any sensitivi-
ty analyses.
3. Discussion
Nutrition plays an important role within the multifactorial
susceptibility of this syndrome; however, up to the present no
systematic review addressed the effectiveness of nutritional
interventions for the treatment of frailty. The systematic
speciﬁcally reviews identiﬁed in the literature on this topic
emphasize interventions related to physical activity without any
particular focus to nutritional interventions, which were
generally analyzed brieﬂy and in a secondary manner.[9,13,17–22]
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